{
    "clinical_study": {
        "@rank": "48729", 
        "acronym": "Postablation", 
        "arm_group": [
            {
                "arm_group_label": "Hydrothermal ablation", 
                "arm_group_type": "Experimental", 
                "description": "Uterine ablation performed with a device that circulates heated water inside the uterus"
            }, 
            {
                "arm_group_label": "radiofrequency energy", 
                "arm_group_type": "Active Comparator", 
                "description": "ablation performed with a device that uses radiofrequency energy."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the shape, size and appearance of the inside of the\n      uterus six months following an endometrial ablation procedure. Half of the participants will\n      have their ablation performed with a hydrothermal ablation device and the other half will\n      have their ablation performed with a device that uses radiofrequency energy."
        }, 
        "brief_title": "Evaluation of the Endometrial Cavity After Endometrial Ablation", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Menorrhagia", 
        "condition_browse": {
            "mesh_term": "Menorrhagia"
        }, 
        "detailed_description": {
            "textblock": "The purpose of this study is to evaluate the shape, size and appearance of the inside of the\n      uterus six months following an endometrial ablation procedure. Half of the participants will\n      have their ablation performed with a hydrothermal ablation device and the other half will\n      have their ablation performed with a device that uses radiofrequency energy. Participants\n      are randomly assigned to one or the other device.\n\n      A vaginal ultrasound will be performed before the procedure and again at six months\n      post-procedure.\n\n      The inside of the uterus will be visualized via hysteroscopy before the procedure and again\n      at six months post-procedure. Measurements will be taken and the investigator will compare\n      photos taken pre-procedure and six months post-procedure."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Premenopausal women Not pregnant and no future pregnancy desired Willing to randomize\n             the device used for the ablation Willing to undergo diagnostic hysteroscopy with\n             office-based anesthesia 6 months post-ablation\n\n        Exclusion Criteria:\n\n          -  Pregnancy or desiring future pregnancy Endometrial hyperplasia Presence of active\n             endometriosis Active pelvic inflammatory disease Previous endometrial ablation\n             procedure"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "51 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 10, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02087228", 
            "org_study_id": "013-053", 
            "secondary_id": "BRI-2013-1979"
        }, 
        "intervention": [
            {
                "arm_group_label": "Hydrothermal ablation", 
                "description": "Heated water is circulated inside the uterus to destroy the lining of the uterus", 
                "intervention_name": "Genesys HydroTherm Ablator", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "radiofrequency energy", 
                "intervention_name": "radiofrequency energy ablation device", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "Endometrial ablation, menorrhagia", 
        "lastchanged_date": "March 12, 2014", 
        "location": {
            "contact": {
                "email": "cathy.frisinger1@baylorhealth.edu", 
                "last_name": "Cathy Frisinger, MPH", 
                "phone": "817-922-2574"
            }, 
            "contact_backup": {
                "email": "theresa.cheyne@baylorhealth.edu", 
                "last_name": "Theresa Cheyne, BSN", 
                "phone": "817-922-2579"
            }, 
            "facility": {
                "address": {
                    "city": "Fort Worth", 
                    "country": "United States", 
                    "state": "Texas", 
                    "zip": "76104"
                }, 
                "name": "Texas Health Care"
            }, 
            "investigator": {
                "last_name": "Delbert A Johns, M.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Evaluation of the Endometrial Cavity After Endometrial Ablation", 
        "overall_contact": {
            "email": "cathy.frisinger1@baylorhealth.edu", 
            "last_name": "Cathy Frisinger, MPH, MS", 
            "phone": "817-922-2574"
        }, 
        "overall_contact_backup": {
            "email": "theresa.cheyne@baylorhealth.edu", 
            "last_name": "Theresa Cheyne, BSN", 
            "phone": "817-922-2579"
        }, 
        "overall_official": {
            "affiliation": "Texas Health Care, Baylor Research Institute", 
            "last_name": "Delbert A Johns, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The inside of the uterus will be visualized via hysteroscopy to determine the amount of scarring", 
            "measure": "Visualization of the inside of the uterus", 
            "safety_issue": "No", 
            "time_frame": "6 months post-ablation"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02087228"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Measurements will be taken of the uterine cavity length and endometrial thickness", 
            "measure": "Measurments of endometrial thickness", 
            "safety_issue": "No", 
            "time_frame": "6 months post-ablation"
        }, 
        "source": "Baylor Research Institute", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Baylor Research Institute", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}